Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

Gingival Crevicular Fluid Zinc- and Aspartyl-binding Protease Profile of Individuals with Moderate/Severe Atopic Dermatitis

Version 1 : Received: 30 September 2020 / Approved: 1 October 2020 / Online: 1 October 2020 (08:55:12 CEST)

How to cite: Valenzuela, F.; Fernández, J.; Aroca, M.; Jiménez, C.; Albers, D.; Hernández, M.; Fernández, A. Gingival Crevicular Fluid Zinc- and Aspartyl-binding Protease Profile of Individuals with Moderate/Severe Atopic Dermatitis. Preprints 2020, 2020100005 (doi: 10.20944/preprints202010.0005.v1). Valenzuela, F.; Fernández, J.; Aroca, M.; Jiménez, C.; Albers, D.; Hernández, M.; Fernández, A. Gingival Crevicular Fluid Zinc- and Aspartyl-binding Protease Profile of Individuals with Moderate/Severe Atopic Dermatitis. Preprints 2020, 2020100005 (doi: 10.20944/preprints202010.0005.v1).

Abstract

Atopic dermatitis (AD) is a protease-modulated chronic disorder with heterogenous clinical manifestations which may lead to an imprecise diagnosis. So far, there are no diagnostic protease tests for AD. We explored the gingival crevicular fluid (GCF) protease profile of periodontally-healthy individuals with moderate/severe AD compared to healthy controls. An exploratory case-control study was conducted. Matching AD patients (n=6) and controls (n=6) were enrolled at the International Center for Clinical Studies, Santiago, Chile. Complete dermatological and periodontal evaluations (involving the collection of GCF samples) were made. The levels of 35 proteases were analyzed using a human protease antibody array. The GCF levels of zinc-binding ADAM8, ADAM9, MMP8 and Neprilysin/CD10, aspartyl-binding Cathepsin E, and serin-binding Protein convertase9 and uPA/Urokinase proteases were lower in moderate/severe AD patients compared to controls (p<0.05). No inter-group differences in the levels of the other 28 proteases were found. MMP8, Cathepsin E and ADAM9 were the biomarkers with the highest sensitivity and specificity regarding the detection of AD (p < 0.05). The area under receiver operating characteristic (ROC) curve for MMP-8+ADAMP-9 was 0.90. In conclusion, differences in the protease profile between AD and control patients associated with MMP8, Cathepsin E and ADAM9. MMP8, ADAM9 and Cathepsin E may be useful as combined diagnostic and therapeutic biomarkers of moderate/severe AD.

Subject Areas

Enzymes, Peptide Hydrolases, Metalloproteases, Biomarkers, Gingival Crevicular Fluid, Atopic Dermatitis

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.